Taming the body’s immune response could offer treatment option for coronavirus

ap wide e ec eaf f cae c
Credit: Felipe Dana/AP

Among the many outstanding questions about COVID-19 is how the same virus, SARS-CoV-2, can kill some patients and leave others unaware they were ever exposed. Clinical evidence combined with hints from laboratory research indicate that for at least some patients with severe cases, the primary danger comes from a runaway immune response that irreparably injures tissue, researchers say. Understanding the mechanisms behind that response could be key to finding a treatment for those patients.

It appears that after infection, the virus replicates itself inside a patient, leading to a disease phase where the immune system mounts an inflammatory response against the invader, says Charles Dela Cruz, a pulmonologist at Yale School of Medicine who is researching COVID-19. Then, in those patients who progress to severe disease, “potentially this inflammatory response is too much and hyper-inflames, causing a lot of side effects in terms of tissue damage and organ failure and things like that,” he says. 

Related article:  Using patient registries to track effectiveness of cell and gene therapy trials

[Randy Cron, a rheumatologist at the University of Alabama at Birmingham] suspects that the answer to why some patients with COVID-19 develop cytokine storms while others don’t may be partly genetic. … He doesn’t know of any current effort to look for such mutations in COVID-19 patients, but expects they will happen eventually.


Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend